Recent Quotes
My Watchlist
Indicators
Markets
Stocks
Funds
Tools
Overview
News
Currencies
International
Treasuries

Athersys Inc (NQ: ATHX )

1.635 USD -0.055 (-3.25%)
Streaming Delayed Price Updated: 12:33 PM EDT, May 17, 2021 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All news about Athersys Inc

< Previous 1 2 3 4 5 6 7 8 9
...
29 30 Next >
12 Health Care Stocks Moving In Friday's After-Market Session
Gainers Evaxion Biotech (NASDAQ:EVAX) shares moved upwards by 16.07% to $6.5 during Friday's after-market session. Trading volume for ... 
Tags AVDL Movers Benzinga
From Benzinga
The Daily Biotech Pulse: Minerva, InflaRx Report Positive Data Readouts, Lucira COVID-19 Test Kit Available On Amazon, Decision Day For Heron
Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting ... 
Tags LHDX AKUS MRKR
From Benzinga
The Daily Biotech Pulse: FDA Authorizes Pfizer-BioNTech COVID-19 Vaccine For Adolescents, Lilly Strikes R&D Collaboration, Vaccine Stocks Novavax, Inovio Sink On Earnings
Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech Stocks Hitting ... 
Tags AVIR GLTO RHHBY
From Benzinga
Stocks That Hit 52-Week Lows On Monday
Monday morning saw 78 companies set new 52-week lows. Intriguing Points: The largest company by market cap to set a ... 
Tags AGRX KRBP Market News
From Benzinga
The Daily Biotech Pulse: Split Verdict For Chemocentryx, NKarta-CRISPR In Cell Therapy Collaboration, Orphazyme's Clinical Trial Setback, 2 IPOs
Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting ... 
Tags SLNO FLDM OYST
From Benzinga
Athersys (ATHX) Q1 2021 Earnings Call Transcript
ATHX earnings call for the period ending March 31, 2021. 
Tags ATHX Market News
From Motley Fool
Athersys Reports First Quarter 2021 Results
Athersys reports First Quarter 2021 financial results and will provide a corporate update today at 4:30 PM EDT. 
From Business Wire News Releases
The Daily Biotech Pulse: Merck's Keytruda Snags Another FDA Approval, Moderna Slips On Revenue Miss, Chemocentryx Adcom
Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech Stocks Hitting ... 
Tags Earnings MTCR VYGR
From Benzinga
Week Ahead In Biotech (May 2-8): ChemoCentryx Adcom, Ophthalmology Conference Presentations, Earnings Deluge
Biopharma stocks experienced volatility in the week ended April 30, as stocks reacted to earnings, data readouts and a handful of FDA ... 
Tags LUMO NTLA NVCN
From Benzinga
Athersys to Present at the Bank of America Virtual Healthcare Conference on May 12
Ivor Macleod, CFO of Athersys Inc. is scheduled to speak at the Bank of America Securities 2021 Virtual Health Care Conference on May 12th. 
From Business Wire News Releases
First Week of ATHX June 18th Options Trading
Investors in Athersys Inc (ATHX) saw new options become available this week, for the June 18th expiration. At Stock Options Channel, our YieldBoost formula has looked up and down the ATHX options chain... 
Tags Stocks
From Market News Video
Athersys to Host First Quarter Financial Results Call
Athersys, Inc. will host its first quarter 2021 financial results call on Thursday, May 6, 2021 at 4:30 PM EDT. 
From Business Wire News Releases
Athersys to Present at the Needham Virtual Healthcare Conference on April 14
Athersys will present a corporate overview at the 20th Annual Needham Virtual Healthcare Conference on April 14th and the event will be webcast. 
From Business Wire News Releases
Why Athersys Stock Jumped Today
The biotech's partner completed enrollment in a key clinical study. 
Tags Market News ATHX
From Motley Fool
Athersys Reports That Healios Has Completed Enrollment in the ONE-BRIDGE Study of MultiStem® for Acute Respiratory Distress Syndrome in Japan
Athersys partner in Japan, HEALIOS KK, completes enrollment in the ONE-BRIDGE study evaluating MulitiStem cell therapy for the treatment of ARDS. 
From Business Wire News Releases
The Daily Biotech Pulse: FDA Nod For Astellas, Seagen, Gilead Get Positive Regulatory Tidings From Europe, 3 IPOs
Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting ... 
Tags RHHBY Benzinga CNTB
From Benzinga
Athersys (ATHX) Q4 2020 Earnings Call Transcript
ATHX earnings call for the period ending December 31, 2020. 
Tags ATHX Market News
From Motley Fool
Athersys Announces Financial Results for Fourth Quarter and Full Year 2020
Athersys continues to develop large-scale manufacturing processes and advance MultiStem cell therapy clinical trials for stroke, ARDS, and trauma. 
From Business Wire News Releases
The Daily Biotech Pulse: Bristol-Myers Squibb's Skin Cancer Readout, Cellect Strikes Reverse Merger Deal, Lava Therapeutics Makes Nasdaq Debut
Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech Stocks Hitting ... 
Tags CNTB OCDX PFE
From Benzinga
Earnings Scheduled For March 25, 2021
Companies Reporting Before The Bell • ARKO (NASDAQ:ARKO) is expected to report earnings for its fourth ... 
Tags IH TLS AWH
From Benzinga
FDA Decisions For Pfizer, Eli Lilly And Bluebird Bio, Bristol-Meyers Squibb, Plus New Data And Earnings
Biotech stocks reversed course in the week ended March 19 amid mixed news flow on data readouts and lackluster broader market ... 
Tags pharmaceuticals FBRX BIOL
From Benzinga
Interesting ATHX Call Options For May 21st
Investors in Athersys Inc (ATHX) saw new options become available this week, for the May 21st expiration. At Stock Options Channel, our YieldBoost formula has looked up and down the ATHX options chain... 
Tags Stocks
From Market News Video
VTWG's Holdings Imply 10% Gain Potential
Looking at the underlying holdings of the ETFs in our coverage universe at ETF Channel, we have compared the trading price of each holding against the average analyst 12-month forward target price, and... 
Tags ETFs
From ETF Channel
Thinking about buying stock in Lipocine, Athersys, Norwegian Cruise Line, Newage Inc, or GameStop?
InvestorsObserver issues critical PriceWatch Alerts for LPCN, ATHX, NCLH, NBEV, and GME. 
From PR Newswire
Athersys to Host Year-End 2020 Financial Results Call
Athersys will host the year-end 2020 financial results call on March 25th. 
From Business Wire News Releases
Athersys Announces Cooperation Agreement With HEALIOS K.K.
Athersys and Healios commit to work in good faith to finalize negotiations important to successful commercialization in Japan. 
From Business Wire News Releases
Athersys Announces CEO Transition
Gil Van Bokkelen to Step Down as Chairman and CEO of Athersys 
From Business Wire News Releases
How The Pieces Add Up: LABU Headed For $205
Looking at the underlying holdings of the ETFs in our coverage universe at ETF Channel, we have compared the trading price of each holding against the average analyst 12-month forward target price, and... 
Tags ETFs
From ETF Channel
Athersys to Host a Virtual Investor Day
Athersys will host a virtual investor day event on February 16th to cover development progress and commercial manufacturing plans. 
From Business Wire News Releases
38 Stocks Moving in Tuesday's Pre-Market Session
Gainers Koss Corporation (NASDAQ: KOSS) shares rose 69% to $10.17 in pre-market trading. Koss gained around 80% on Monday as the ... 
Tags ATHX PSAC APO
From Benzinga
< Previous 1 2 3 4 5 6 7 8 9
...
29 30 Next >
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.